Atlas Trials

Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

Clinical trial NCT02271412 · COMPLETED

Trial details

NCT number
NCT02271412
Sponsor
Luye Pharma Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder, Recurrent, Unspecified
Start date
2014-10-01
Primary completion
2015-03-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.